| Veröffentlichte Version Download ( PDF | 2MB) | Lizenz: Creative Commons Namensnennung-NichtKommerziell-KeineBearbeitung 3.0 de |
Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands †
Pockes, Steffen, Wifling, David
, Buschauer, Armin
und Elz, Sigurd
(2019)
Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands †.
ChemistryOpen 8 (3), S. 285-297.
Veröffentlichungsdatum dieses Volltextes: 16 Dez 2019 09:37
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.41284
Zusammenfassung
New classes of alkylated hetarylpropylguanidines with different functionality and variation in spacer length were synthesized to determine their behavior at the four histamine receptor (H1R, H2R, H3R, H4R) subtypes. Alkylated guanidines with different terminal functional groups and varied basicity, like amine, guanidine and urea were developed, based on the lead structure SK&F 91486 (2). ...
New classes of alkylated hetarylpropylguanidines with different functionality and variation in spacer length were synthesized to determine their behavior at the four histamine receptor (H1R, H2R, H3R, H4R) subtypes. Alkylated guanidines with different terminal functional groups and varied basicity, like amine, guanidine and urea were developed, based on the lead structure SK&F 91486 (2). Furthermore, heteroatomic exchange at the guanidine structure of 2 led to simple analogues of the lead compound. Radioassays at all histamine receptor subtypes were accomplished, as well as organ bath studies at the guinea pig (gp) ileum (gpH(1)R) and right atrium (gpH(2)R). Ligands with terminal functionalization led to, partially, highly affine and potent structures (two digit nanomolar), which showed up a bad selectivity profile within the histamine receptor family. While the benzoylurea derivative 144 demonstrated a preference towards the human (h) H3R, S-methylisothiourea analogue 143 obtained high affinity at the hH(4)R (pK(i)=8.14) with moderate selectivity. The molecular basis of the latter finding was supported by computational studies.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | ChemistryOpen | ||||
| Verlag: | Wiley | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | WEINHEIM | ||||
| Band: | 8 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 3 | ||||
| Seitenbereich: | S. 285-297 | ||||
| Datum | 5 März 2019 | ||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische / Medizinische Chemie I (Prof. Elz) | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; IN-VITRO PHARMACOLOGY; H-4 RECEPTOR; H3 RECEPTOR; HIGHLY POTENT; 1ST POTENT; H-2-RECEPTOR; CLONING; AGONIST; BINDING; histamine H1-4 receptor; ligand design; receptor subtype selectivity; organ pharmacology; computational chemistry | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-412846 | ||||
| Dokumenten-ID | 41284 |
Downloadstatistik
Downloadstatistik